Jodi Craigo

Title: Jodi Craigo: Innovator in Vaccine Development

Introduction

Jodi Craigo is a prominent inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of vaccine development, particularly in the area of lentivirus-related diseases. With a total of 2 patents, her work has the potential to impact both veterinary and human medicine.

Latest Patents

One of Jodi Craigo's latest patents is the EIAV p26 deletion vaccine and diagnostic. This innovative vaccine provides immunity to mammals from infections caused by various lentiviruses, including equine infectious anemia virus, human immunodeficiency virus (HIV), feline immunodeficiency virus (FIV), bovine immunodeficiency virus (BIV), and simian immunodeficiency virus (SIV). The composition of this vaccine includes a deletion in a gene that blocks the replication of the virus in vivo. This invention allows for the safe vaccination of equines without converting to a seropositive status on the Coggin's Test or any other test that measures p26.

Career Highlights

Throughout her career, Jodi has worked with notable companies, including Akzo Nobel N.V. Her expertise in vaccine development has positioned her as a key figure in the field, contributing to advancements that could lead to better health outcomes for both animals and humans.

Collaborations

Jodi has collaborated with esteemed colleagues such as Ronald C. Montelaro and Charles Issel. These partnerships have further enhanced her research and development efforts in the field of immunology.

Conclusion

Jodi Craigo's innovative work in vaccine development showcases her dedication to advancing medical science. Her contributions, particularly in the area of lentivirus vaccines, highlight the importance of research in improving health outcomes.